Clinical Trials on Suicidal Ideation in Japan

Total 13 results

Novartis Pharmaceuticals

Terminated

Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent

Major Depressive Disorder With Suicidal Ideation With Intent

Taiwan, Spain, Germany, Netherlands, Turkey, Mexico, United States, Malaysia, Poland, Canada, Japan, Russian Federation, Argentina, Brazil
Pfizer

Recruiting

A Study to Learn About the Study Medicine - Precedex in Children From Japan.

Sedation

Japan
Pfizer
Maruishi Pharmaceutical

Completed

Precedex Special Investigation (in Pediatric Patients)

Sedation

Japan
Pfizer
Maruishi Pharmaceutical

Completed

Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery With Epidural Anesthesia or Spinal Anesthesia Without Intubation

Sedation

Japan
Pfizer
Maruishi Pharmaceutical

Completed

Study of DA-9501 In Pediatric Subjects In The Intensive Care Unit

ICU Sedation

Japan
Hospira, now a wholly owned subsidiary of Pfizer
Maruishi Pharmaceutical

Completed

Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery or Medical Procedure Without Intubation

Sedation

Japan
AstraZeneca
Johnson & Johnson

Completed

Phase III Study of ICI35,868 (Diprivan) With and Without EES0000645/A (SDS) on Gastrointestinal Endoscopy (Kagami_SDS)

Sedation to be Moderate for a Diagnostic Gastrointestinal Endoscopy and Gastrointestinal Endoscopic Polypectomy

Japan
Hospira, now a wholly owned subsidiary of Pfizer
Maruishi Pharmaceutical

Completed

Long-term Clinical Study Evaluating the Safety and Efficacy of Dexmedetomidine in ICU Subjects

Sedation

Japan
Hospira, now a wholly owned subsidiary of Pfizer
Maruishi Pharmaceutical

Completed

Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients

Conscious Sedation

Japan
Japan Foundation for Neuroscience and Mental Health
National Center of Neurology and Psychiatry, Japan

Completed

RCT of Post-Suicide Attempt Case Management (ACTION-J) (ACTION-J)

Suicide Attempt

Japan
Pfizer

Completed

Safety and Efficacy of Dexmedetomidine (DEX) for Sedation of Subjects ≥1 Month to <17 Years Undergoing MRI Scans

MRI Sedation

United States, Japan
Aomori University of Health and Welfare

Completed

A Community-based Depression Screening Intervention for Middle-aged Suicide

Suicide

Japan
Japan Foundation for Neuroscience and Mental Health
National Center of Neurology and Psychiatry, Japan

Completed

A Community Intervention Trial of Multimodal Suicide Prevention Program in Japan (NOCOMIT-J) (NOCOMIT-J)

Suicide

Japan

3

Subscribe